Showing results (1161-1170 of 1,755) with videos related to

Sort By:
Pageof 176
Onkologie|February 1, 1991
Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer SocietyK Possinger, H Wagner, P Worst, et al.
BMC Medical Genomics|May 26, 2025
A case of congenital heart defects and familial exudative vitreoretinopathy caused by activation of a cryptic splice donor in NOTCH1Joseph Farris, Camila Dergam-Larson, Madeline Lopour, et al.
JIMD Reports|October 15, 2017
Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency: Unique Presenting Laboratory Values and a Review of Biochemical and Clinical FeaturesErin Conboy, Filippo Vairo, Matthew Schultz, et al.
Elife|January 20, 2023
A CRISPR screen in intestinal epithelial cells identifies novel factors for polarity and apical transportKatharina M C Klee, Michael W Hess, Michael Lohmüller, et al.
Archives of Internal Medicine|November 25, 1996
Predictive properties of serum-prostate-specific antigen testing in a community-based settingS J Jacobsen, E J Bergstralh, H A Guess, et al.
Antioxidants (Basel, Switzerland)|March 29, 2023
Neuroimaging in Primary Coenzyme-Q<sub>10</sub>-Deficiency DisordersJuliane Münch, Jannik Prasuhn, Lucia Laugwitz, et al.
Nanomedicine (London, England)|December 20, 2008
Human neural cell interactions with orientated electrospun nanofibers in vitroJose Gerardo-Nava, Tobias Führmann, Kristina Klinkhammer, et al.
Tissue Engineering. Part C, Methods|December 17, 2008
Deposition of electrospun fibers on reactive substrates for in vitro investigationsKristina Klinkhammer, Nadine Seiler, Dirk Grafahrend, et al.
Microbial Cell Factories|April 17, 2009
Process development in Hansenula polymorpha and Arxula adeninivorans, a re-assessmentChristoph Stöckmann, Marco Scheidle, Barbara Dittrich, et al.
Journal of Medicinal Chemistry|June 1, 1986
Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivityT R Burke, A E Jacobson, K C Rice, et al.
Pageof 176